about
Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationMMP-8 promotes polymorphonuclear cell migration through collagen barriers in obliterative bronchiolitisMinimal acute rejection in pediatric lung transplantation--does it matter?Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.Prediction of BOS by the single-breath nitrogen test in double lung transplant recipients.Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipientsAntibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease.The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.Guidelines on the use of extracorporeal photopheresisInhaled cyclosporine and pulmonary function in lung transplant recipients.Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantationThe Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation.De novo-developed antibodies to donor MHC antigens lead to dysregulation of microRNAs and induction of MHC class IISurveillance bronchoscopy in children during the first year after lung transplantation: Is it worth it?Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17.Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.Clinical Outcomes of Heart-Lung Transplantation: Review of 10 Single-Center Consecutive Patients.Bronchoalveolar immunologic profile of acute human lung transplant allograft rejectionUpdate on lung transplantation.Modulation of immune responses following solid organ transplantation by microRNA.Chronic lung allograft dysfunction after lung transplantation: the moving target.Green tea epigallo-catechin-galleate ameliorates the development of obliterative airway disease.A human-mouse chimeric model of obliterative bronchiolitis after lung transplantation.Alcohol primes the airway for increased interleukin-13 signaling.T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.Bone marrow-derived multipotent stromal cells attenuate inflammation in obliterative airway disease in mouse tracheal allografts.Conditional depletion of airway progenitor cells induces peribronchiolar fibrosis.Bronchiolitis obliterans following lung transplantation: early detection using computed tomographic scanningLow-molecular-weight heparins do not modify obliterative airway disease in rat tracheal allografts.Increased levels of T cell granzyme b in bronchiolitis obliterans syndrome are not suppressed adequately by current immunosuppressive regimens.Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection.Divergent Function of Programmed Death-Ligand 1 in Donor Tissue versus Recipient Immune System in a Murine Model of Bronchiolitis Obliterans.Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients.Effectiveness of long-term routine pulmonary function surveillance following pediatric hematopoietic stem cell transplantation.
P2860
Q30439172-0B1EA680-F959-4849-BF3D-EAAD9ECFC950Q33571189-5E1E8C96-46BB-4B01-9C54-1DE59B04F33FQ33925168-6CA50B32-27DA-4BE5-AD82-B38A5167A4C1Q33950112-C2D18EC4-D7E8-4BE7-B524-FDCEF44A5891Q34084066-F1D4B822-4406-417E-BAD4-15F70DEC50E2Q34172126-F28AAD5E-0F64-4646-8984-16CDA12F0D93Q34382434-213172EF-1F16-47B1-A862-3F1031CFECBEQ34447908-7D55F463-1DC3-48B1-98FD-2B83251D672CQ34583529-0ECEA92B-F4F1-406A-81FF-471DB44F7167Q34918643-44F49A37-4BA0-4CBF-BEC2-3C0EC84F3314Q35132453-5E18BDAA-0B06-49FF-9310-2F3A20D5FD2DQ35168136-E61503A8-B26A-42B9-818C-A672F8A56BF2Q35195122-C8EA089E-8247-47A1-B13D-2F55937D66A3Q35691072-3A01F298-580D-4F8F-BD0B-BC2F5ECD880CQ36203330-846F0A25-AD36-408E-884C-515EC1105663Q36225775-D3FC8A03-605D-42DA-9BFC-9F8D3A04ED05Q36292047-B1DB88AA-F1DB-4A32-87AD-2E3ACADDBDEDQ36330564-E7122ACD-2F42-4238-A9FA-EA6111722731Q36915514-1260F160-0ECB-4A6F-9777-B1E63395D46EQ36989186-0F7FECCB-2A8A-4E23-BD04-3CBDAD0A03FCQ37347729-DA322295-A59A-436F-AFB8-30001E373737Q37362628-85627915-8840-4630-834F-6D3EB7F97CFCQ38049411-D6EA6F52-BB0E-4010-9C1C-1BA1F7DDC1FDQ38058746-D85EE7AE-0356-4034-A7C6-E7F29CF5C83BQ38333138-428ED68A-7B3D-457D-80BC-5606EC254F8AQ41784100-9531B3DD-C9EA-4DF4-A3F3-D772BC1917BAQ41814010-04E51C9F-361F-4F8A-B48E-2D4989978018Q41966454-CD0C7225-1889-48DB-9DBF-8D9086937B7DQ42045956-A8C1DA57-4E52-476E-AA17-242099C05738Q42683461-15A2E365-3736-4FD4-8B67-4C13D1D85E4BQ42764454-E5B35592-80DC-4207-BE35-655E9529937CQ42879801-92473BFF-D0AD-4C72-805C-76DCA9F65B46Q43279667-A7DE6CCB-0F14-48D8-8B29-26F59349FB03Q50800196-28D0B672-E4FD-4A99-A3E8-E3A21CC48663Q51044254-57E3BDB2-AB3C-48DE-BE80-3F021683C92EQ54289718-C31F5094-BA6F-44C8-89FF-DB0A3C02B9EAQ54296431-12EBFF5E-EA32-4392-8212-E24BCD5FC3D4
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Post-transplant bronchiolitis obliterans.
@ast
Post-transplant bronchiolitis obliterans.
@en
type
label
Post-transplant bronchiolitis obliterans.
@ast
Post-transplant bronchiolitis obliterans.
@en
prefLabel
Post-transplant bronchiolitis obliterans.
@ast
Post-transplant bronchiolitis obliterans.
@en
P1476
Post-transplant bronchiolitis obliterans.
@en
P2093
P304
P356
10.1183/09031936.03.00039103
P577
2003-12-01T00:00:00Z